Amber L. Morey
University of California San Diego
ORCID: 0000-0003-3401-9853Also affiliated with Sanford Consortium for Regenerative Medicine, VLP Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Martin Ng, Michail Spanos, Piyan Zhang, Tuoye Xu, Willi Cheung +20 more
Papers
Driven by 4 papers — median percentile 45. Top paper: “Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine”.
Amber L. Morey, Andrés A. Quiñones-Molina, Josiane Fofana, Luis Romero, Elizabeth Peters +6 more
Martin Ng, Michail Spanos, Piyan Zhang, Tuoye Xu, Willi Cheung +20 more
Jennifer Jones, Roger P. Alexander, Eric Alsop, Ji Yeong An, Mohammad H. Asghari +91 more
Mai Komori, Amber L. Morey, Andrés A. Quiñones-Molina, James B. Hood, Josiane Fofana +15 more